全文获取类型
收费全文 | 2615篇 |
免费 | 194篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 21篇 |
儿科学 | 107篇 |
妇产科学 | 31篇 |
基础医学 | 286篇 |
口腔科学 | 50篇 |
临床医学 | 210篇 |
内科学 | 711篇 |
皮肤病学 | 75篇 |
神经病学 | 141篇 |
特种医学 | 119篇 |
外科学 | 392篇 |
综合类 | 100篇 |
一般理论 | 1篇 |
预防医学 | 135篇 |
眼科学 | 55篇 |
药学 | 207篇 |
中国医学 | 12篇 |
肿瘤学 | 163篇 |
出版年
2022年 | 19篇 |
2021年 | 52篇 |
2020年 | 24篇 |
2019年 | 41篇 |
2018年 | 42篇 |
2017年 | 39篇 |
2016年 | 49篇 |
2015年 | 55篇 |
2014年 | 60篇 |
2013年 | 79篇 |
2012年 | 122篇 |
2011年 | 152篇 |
2010年 | 71篇 |
2009年 | 78篇 |
2008年 | 98篇 |
2007年 | 111篇 |
2006年 | 104篇 |
2005年 | 97篇 |
2004年 | 92篇 |
2003年 | 69篇 |
2002年 | 62篇 |
2001年 | 58篇 |
2000年 | 81篇 |
1999年 | 53篇 |
1998年 | 34篇 |
1997年 | 31篇 |
1996年 | 23篇 |
1995年 | 26篇 |
1994年 | 17篇 |
1992年 | 80篇 |
1991年 | 39篇 |
1990年 | 53篇 |
1989年 | 39篇 |
1988年 | 47篇 |
1987年 | 45篇 |
1986年 | 36篇 |
1985年 | 37篇 |
1984年 | 27篇 |
1983年 | 17篇 |
1982年 | 18篇 |
1979年 | 41篇 |
1978年 | 24篇 |
1977年 | 26篇 |
1975年 | 23篇 |
1974年 | 26篇 |
1973年 | 37篇 |
1972年 | 32篇 |
1971年 | 22篇 |
1970年 | 20篇 |
1935年 | 16篇 |
排序方式: 共有2816条查询结果,搜索用时 0 毫秒
31.
Sudhir Tauro Charles Craddock Karl Peggs Gulnaz Begum Premini Mahendra Gordon Cook Judith Marsh Donald Milligan Anthony Goldstone Ann Hunter Asim Khwaja Raj Chopra Timothy Littlewood Andrew Peniket Anne Parker Graham Jackson Geoff Hale Mark Cook Nigel Russell Stephen Mackinnon 《Journal of clinical oncology》2005,23(36):9387-9393
PURPOSE: The toxicity of allogeneic stem-cell transplantation can be substantially reduced using a reduced-intensity conditioning (RIC) regimen. This has increased the proportion of patients with myeloid malignancies eligible for allogeneic transplantation. However, the capacity of RIC allografts to produce durable remissions in patients with acute myeloid leukemia (AML) and myelodysplasia (MDS) has not yet been defined, and consequently, the role of RIC allografts in the management of these diseases remains conjectural. PATIENTS AND METHODS: Seventy-six patients with high-risk AML or MDS received an allograft using a fludarabine/melphalan RIC regimen incorporating alemtuzumab. The median age of the cohort was 52 years (range, 18 to 71 years). RESULTS: The 100-day transplantation-related mortality rate was 9%, and no patient developed greater than grade 2 graft-versus-host disease. With a median follow-up of 36 months (range, 13 to 70 months), 27 patients were alive and in remission, with 3-year actuarial overall survival (OS) and disease-free survival (DFS) rates of 41% and 37%, respectively. The 3-year OS and DFS rates of patients with AML in complete remission at the time of transplantation were 48% and 42%, respectively. Disease relapse was the most common cause of treatment failure and occurred at a median time of 6 months after transplantation. All but one patient destined to relapse did so within 24 months of transplantation. CONCLUSION: The extended follow-up in this series identifies a high risk of early disease relapse but provides evidence that RIC allografts can produce sustained DFS in a significant number of patients with AML who would be ineligible for allogeneic transplantation with myeloablative conditioning. 相似文献
32.
33.
Gro Tunheim Gunnar
yvind Isaksson R Adity Chopra Audun Aase AnneMarte Bakken Kran John Torgils Vaage Fridtjof LundJohansen Olav Hungnes 《Influenza and other respiratory viruses》2022,16(6):1004
BackgroundOne year into the COVID‐19 pandemic, the cumulative number of confirmed COVID‐19 cases in Norway was still low. In January 2021, when the Norwegian COVID‐19 vaccination campaign started, the national seroprevalence estimate of SARS‐CoV‐2 antibodies was 3.2%. We have conducted a nationwide cross‐sectional study in August 2021 to investigate the overall prevalence of SARS‐CoV‐2 antibodies in Norway after 8 months of COVID‐19 mass vaccination and a third wave of SARS‐CoV‐2 infection.MethodsResidual sera were collected from laboratories across Norway in August 2021. In IgG antibodies against the spike protein, the spike receptor binding domain (RBD) and the nucleocapsid protein of SARS‐CoV‐2 were measured by a bead‐based flow cytometric assay.ResultsIn total, 1926 residual sera were collected from individuals aged 0–98 years; 55.1% were from women. The overall national estimated seroprevalence from vaccination and/or infection was 62.6% (credible interval [CrI] 60.1%–65.2%) based on having antibodies against both spike and RBD. Estimated seroprevalence increased with age. Among all samples, 11.7% had antibodies against nucleocapsid. For unvaccinated children <12 years, the seroprevalence estimate due to SARS‐CoV‐2 infection was 12.5% (95% CrI 9.3%–16.1%). Of seropositive samples from the unvaccinated children, 31.9% lacked anti‐nucleocapsid antibodies.ConclusionsThe high overall SARS‐CoV‐2 seroprevalence estimates are in line with Norwegian registry data. Vaccination, not infection, contributed the most to the high seroprevalence in August 2021. Lack of antibodies against nucleocapsid should not automatically be interpreted as absence of previous infection as this could lead to underestimation of COVID‐19 cases in seroprevalence studies. 相似文献
34.
35.
36.
Monika Chopra H. S. Rehan Rachna Gupta F. J. Ahmad M. D. Tariq L. K. Gupta 《Indian journal of pharmaceutical sciences》2014,76(5):462-465
For the prevention of postoperative ocular infections prophylactic topical antibiotics are routinely used. Studies evaluating comparative difference between single dose versus multiple dose administration on aqueous humour concentration of moxifloxacin are lacking. This study compared the aqueous humour concentration of moxifloxacin following its topical administration in rabbit eyes with two dose regimens. Twelve albino rabbits were divided into two groups. In group-1, two drops were administered thrice (total six drops) at 2 min intervals, in both the eyes; in group-2, two drops of moxifloxacin were administered three times a day for three days and also two h before aqueous humour collection i.e. on fourth day. Mean aqueous humour concentrations were calculated and compared using Student''s ‘t’ test and P<0.05 was considered significant. Moxifloxacin concentration in aqueous humour in group-1 was 23.79 μg/ml and in group-2 was 42.08 μg/ml. Both dosing regimens produced substantially higher aqueous concentrations than the known minimum inhibitory concentration for most bacteria. Moxifloxacin concentration in aqueous humour with multiple instillations is significantly higher than single instillation (P<0.05), which is adequate to cover ciprofloxacin-resistant gram-negative bacteria. Repeated topical moxifloxacin administration achieved significantly higher aqueous humour concentrations than single administration. 相似文献
37.
38.
Navneet Magon K. M. Babu Krishan Kapur Sanjiv Chopra Gurdarshan Singh Joneja 《Nigerian medical journal》2013,54(5):289-294
Post-partum haemorrhage (PPH) is a life-threatening obstetric complication and the leading cause of maternal death. Any bleeding that results in or could result in haemodynamic instability, if untreated, must be considered as PPH. There is no controversy about the need for prevention and treatment of PPH. The keystone of management of PPH entails first, non-invasive and nonsurgical methods and then invasive and surgical methods. However, mortality remains high. Therefore, new advancements in the treatment are most crucial. One such advancement has been the use of recombinant activated factor VII (rFVIIa) in PPH. First used 12 years back in PPH, this universal haemostatic agent has been effectively used in controlling PPH. The best available indicator of rFVIIa efficacy is the arrest of haemorrhage, which is judged by visual evidence and haemodynamic stabilization. It also reduces costs of therapy and the use of blood components in massive PPH. In cases of intractable PPH with no other obvious indications for hysterectomy, administration of rFVIIa should be considered before surgery. We share our experience in a series of cases of PPH, successfully managed using rFVIIa. 相似文献
39.
40.
Christopher J. Moore Melissa C. Caughey Diane O. Meyer Regina Emmett Catherine Jacobs Manisha Chopra James F. Howard Caterina M. Gallippi 《Ultrasound in medicine & biology》2018,44(12):2519-2530
Our group has previously found that in silico, mechanical anisotropy may be interrogated by exciting transversely isotropic materials with geometrically asymmetric acoustic radiation force excitations and then monitoring the associated induced displacements in the region of excitation. We now translate acoustic radiation force-based anisotropy assessment to human muscle in vivo and investigate its clinical relevance to monitoring muscle degeneration in Duchenne muscular dystrophy (DMD). Clinical anisotropy assessments were performed using Viscoelastic Response ultrasound, with a degree of anisotropy reflected by the ratios of Viscoelastic Response relative elasticity (RE) or relative viscosity (RV) measured with the asymmetric radiation force oriented parallel versus perpendicular to muscle fiber alignment. In vivo results from rectus femoris and gastrocnemius muscles of boys aged ~7.9–10.4 y indicate that RE and RV anisotropy ratios in rectus femoris muscles of boys with DMD were significantly higher than those of healthy control boys (RE: DMD?=?1.51 ± 0.87, control?=?0.99 ± 0.69, p?=?0.04, Wilcoxon rank sum test; RV: DMD?=?1.04 ± 0.71, control?=?0.74 ± 0.22, p?=?0.02). In the gastrocnemius muscle, only the RV anisotropy ratio was significantly higher in dystrophic than control patients (DMD?=?1.23 ± 0.35, control?=?0.88 ± 0.31, p?=?0.04). In the dystrophic rectus femoris muscle, the RE anisotropy ratio was inversely correlated (slope?=?–0.03/lbf, r?=?–0.43, p?=?0.07, Pearson correlation) with quantitative muscle testing functional output measures but was not correlated with quantitative muscle testing in the dystrophic gastrocnemius. These results suggest that Viscoelastic Response RE and RV measures reflect differences in mechanical anisotropy associated with functional impairment with dystrophic degeneration that are relevant to monitoring DMD clinically. 相似文献